| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aged neutrophils fuel tumor progression
|
Reichel, C.A.
|
|
2019
|
110 |
S1 |
p. S1
|
artikel
|
| 2 |
An oncolytic influenza A virus expressing the mycobacterial ESAT-6 protein
|
Lazlo, V.
|
|
2019
|
110 |
S1 |
p. S18
|
artikel
|
| 3 |
A novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors
|
Karches, C.H.
|
|
2019
|
110 |
S1 |
p. S25
|
artikel
|
| 4 |
Anti-hPSMA CAR engineered NK-92 cells: An Off-The-Shelf cellular therapeutic for targeted elimination of prostate cancer cells
|
Zuccolotto, G.
|
|
2019
|
110 |
S1 |
p. S26-S27
|
artikel
|
| 5 |
A plasma-based assay for assessment of tumour mutational burden in patients with metastatic non-small cell lung cancer in the first-line treatment setting: Results from the MYSTIC study
|
Si, H.
|
|
2019
|
110 |
S1 |
p. S2
|
artikel
|
| 6 |
Arming T cells with C-X-C-motive receptor 6 enables adoptive T cell therapy of pancreatic cancer
|
Lesch, S.
|
|
2019
|
110 |
S1 |
p. S25-S26
|
artikel
|
| 7 |
Arming T cells with C-X-C-motive receptor 6 enhances infiltration of pancreatic cancer patient-derived organoids
|
Ogonek, J.
|
|
2019
|
110 |
S1 |
p. S24-S25
|
artikel
|
| 8 |
A screening for novel immune-checkpoints identifies a serine/threonine kinase to confer immune resistance in multiple myeloma
|
Volpin, V.
|
|
2019
|
110 |
S1 |
p. S3-S4
|
artikel
|
| 9 |
Author index
|
|
|
2019
|
110 |
S1 |
p. I-III
|
artikel
|
| 10 |
Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis
|
Groza, D.
|
|
2019
|
110 |
S1 |
p. S23-S24
|
artikel
|
| 11 |
Breast cancer patients have multifunctional tumor-reactive CD4 T cells in both blood and tumor
|
Pinho, M.P.
|
|
2019
|
110 |
S1 |
p. S32
|
artikel
|
| 12 |
Cancer associated mast cells exhibit a tumor promoting phenotype but can be effectively targeted to reinvigorate antitumor immunity in a human based ex-vivo model
|
Ferber, D.
|
|
2019
|
110 |
S1 |
p. S12
|
artikel
|
| 13 |
Characterisation of peripheral blood mononuclear cells in patients with combination ipilimumab and nivolumab therapy-related colitis
|
Sasson, S.C.
|
|
2019
|
110 |
S1 |
p. S21-S22
|
artikel
|
| 14 |
Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models
|
Benmebarek, M.
|
|
2019
|
110 |
S1 |
p. S3
|
artikel
|
| 15 |
Cholesterol induces CD8+ T-cell exhaustion in the tumor microenvironment
|
Yi, Q.
|
|
2019
|
110 |
S1 |
p. S9-S10
|
artikel
|
| 16 |
Clearance of apoptotic bodies by neutrophils induce tissue regenerative responses
|
Brandel, V.
|
|
2019
|
110 |
S1 |
p. S12
|
artikel
|
| 17 |
Clinical relevance of in vitro generated dendritic cells of leukemic origin to predict response to immunotherapy in patients with AML and MDS
|
Freudenreich, M.
|
|
2019
|
110 |
S1 |
p. S29
|
artikel
|
| 18 |
Comparing the immune cell infiltration of colorectal cancer with distant normal mucosa uncovers a prognostically relevant immune cell profile
|
Strasser, K.
|
|
2019
|
110 |
S1 |
p. S8
|
artikel
|
| 19 |
Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma
|
de Ruiter, E.J.
|
|
2019
|
110 |
S1 |
p. S20
|
artikel
|
| 20 |
Complete response of stage IV pancreatic cancer combining low-dose checkpoint inhibitors with interleukin-2 (IL-2) and fever range hyperthermia
|
Kleef, R.
|
|
2019
|
110 |
S1 |
p. S22
|
artikel
|
| 21 |
Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in ‘DC-culture-media’ shifts the (serum) chemokine-release profile to a more ‘inflammatory’ (in culture) going along with improved antileukemic T-cell-reactivity
|
Merle, M.
|
|
2019
|
110 |
S1 |
p. S24
|
artikel
|
| 22 |
Development of an in vitro 3D model system for testing PD-1/PDL-1 immune checkpoint inhibitors
|
Chiovaro, F.
|
|
2019
|
110 |
S1 |
p. S18-S19
|
artikel
|
| 23 |
Differences in macrophage colonization of the colorectal cancer and normal mucosa
|
Strasser, K.
|
|
2019
|
110 |
S1 |
p. S8
|
artikel
|
| 24 |
Differential analysis of complex immune biology in MSI and MSS colorectal tumor microenvironments using high-plex spatial resolution
|
Hinerfeld, D.
|
|
2019
|
110 |
S1 |
p. S27
|
artikel
|
| 25 |
3D micro-tumors for predicting individual treatment responses to immunotherapy
|
Sturmheit, T.
|
|
2019
|
110 |
S1 |
p. S14
|
artikel
|
| 26 |
Effects of the tumor microenvironment generated by glioblastoma multiforme cells over monocyte-derived dendritic cells
|
Chauca Torres, N.
|
|
2019
|
110 |
S1 |
p. S31
|
artikel
|
| 27 |
EGF-based vaccine: Recent immunological results in advanced lung cancer and non-invasive bladder cancer patients
|
Mazorra, Z.
|
|
2019
|
110 |
S1 |
p. S27
|
artikel
|
| 28 |
Establishing of a primary cancer microtissue model to investigate immune cell infiltration
|
Koeck, S.
|
|
2019
|
110 |
S1 |
p. S10
|
artikel
|
| 29 |
Expression of Indoleamine 2,3-dioxygenase in erlotinib-treated patients with advanced pancreatic cancer: Translational results from a multi-center, randomized phase III trial
|
Kruger, S.
|
|
2019
|
110 |
S1 |
p. S16
|
artikel
|
| 30 |
Glycosylation of the cytokine co-receptor gp130 reveals a rapid protein turnover, which gives raise to biased signalling in human melanoma cells from different disease stages
|
Svoboda, K.
|
|
2019
|
110 |
S1 |
p. S11
|
artikel
|
| 31 |
HDAC6 inhibitor ITF3791 enhances alloantigen presentation capabilities of myeloid cells modulating PD-L1 expression and co-stimulatory molecules
|
Ripamonti, C.
|
|
2019
|
110 |
S1 |
p. S14-S15
|
artikel
|
| 32 |
Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis
|
Laengle, J.
|
|
2019
|
110 |
S1 |
p. S5
|
artikel
|
| 33 |
Human lung cancer explants model: Set up of a predictive model for treatment
|
Lenoir, B.M.A.
|
|
2019
|
110 |
S1 |
p. S28
|
artikel
|
| 34 |
Identification and evaluation of novel sarcoma antigens for use with oncolytic vaccines
|
Birdi, H.
|
|
2019
|
110 |
S1 |
p. S16-S17
|
artikel
|
| 35 |
Immune and mutational landscape in triple negative breast cancer and its evolution during neoadjuvant chemotherapy associated or not with GTN and anti-PD-1
|
Mabrouk, N.
|
|
2019
|
110 |
S1 |
p. S4
|
artikel
|
| 36 |
Immune-related effects of the ETS factor inhibitor YK-4-279
|
Dinhof, C.
|
|
2019
|
110 |
S1 |
p. S17
|
artikel
|
| 37 |
Immunogenic effects of FOLFOXIRI plus Bevacizumab therapy in colorectal peritoneal carcinomatosis
|
Birnleitner, H.
|
|
2019
|
110 |
S1 |
p. S7-S8
|
artikel
|
| 38 |
In contrast to other soft tissue sarcomas, GIST shows enhanced numbers of immune checkpoint-negative CD8 T cells
|
Klaver, Y.
|
|
2019
|
110 |
S1 |
p. S9
|
artikel
|
| 39 |
Increased detection of (leukemiaspecific) adaptive and innate immune-reactive cells under treatment of AML-diseased rats and one therapy-refractory AML-patient with blastmodulating, clinically approved response modifiers
|
Atzler, M.
|
|
2019
|
110 |
S1 |
p. S28-S29
|
artikel
|
| 40 |
Induction of a strong and persistent antitumor immune response using liposomal vaccines in the HPV-transformed orthotopic lung tumor model TC-1
|
Jacoberger-Foissac, C.
|
|
2019
|
110 |
S1 |
p. S15
|
artikel
|
| 41 |
Induction of tumor-specific immune responses by the TLR9 agonist EnanDIM in murine syngeneic tumor models
|
Volz, B.
|
|
2019
|
110 |
S1 |
p. S13
|
artikel
|
| 42 |
Innovative antitumoral platinum (II) compounds as chemotherapeutic and immunotherapeutic agents
|
Wantz, M.
|
|
2019
|
110 |
S1 |
p. S31-S32
|
artikel
|
| 43 |
In-situ diversification of immunity following vaccination targeting tumor neoepitopes; an integral component of combinatorial immunotherapy
|
Lee, K.L.
|
|
2019
|
110 |
S1 |
p. S4-S5
|
artikel
|
| 44 |
Interlaboratory variation in PD-L1 positivity in non-small cell lung cancer patients: a nationwide study
|
Koomen, B.M.
|
|
2019
|
110 |
S1 |
p. S19
|
artikel
|
| 45 |
Interleukin-37b exerts antitumor activity on gallbladder cancer cell line
|
Lerthirunvibul, N.
|
|
2019
|
110 |
S1 |
p. S30
|
artikel
|
| 46 |
Irradiated cancer exosomes promote M1-like polarization of macrophages and enhance their anti-tumoral responses
|
Stary, V.
|
|
2019
|
110 |
S1 |
p. S32-S33
|
artikel
|
| 47 |
Keyword Index
|
|
|
2019
|
110 |
S1 |
p. IV
|
artikel
|
| 48 |
Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in non-small cell lung carcinoma patients responding to atezolizumab treatment
|
Fehlings, M.
|
|
2019
|
110 |
S1 |
p. S2-S3
|
artikel
|
| 49 |
Lipid-storing, tumor-associated macrophages orchestrate a tumor-excluded immune landscape in omentum metastases of epithelial ovarian cancer
|
Suarez-Carmona, M.
|
|
2019
|
110 |
S1 |
p. S11-S12
|
artikel
|
| 50 |
LL-37 inhibits pancreatic cancer development through inhibition of autophagy and reprogramming of the tumor microenvironment
|
Ko, J.K.
|
|
2019
|
110 |
S1 |
p. S5-S6
|
artikel
|
| 51 |
Mechanism of action of NKTR-214, a first-in-class, CD122-preferential IL-2 pathway agonist
|
Overwijk, W.W.
|
|
2019
|
110 |
S1 |
p. S17
|
artikel
|
| 52 |
MiRNA deregulation can contribute to breakdown of MHC I class antigen processing and presenting machinery in breast cancer cells
|
Halytskiy, V.A.
|
|
2019
|
110 |
S1 |
p. S19
|
artikel
|
| 53 |
Modulated electro hyperthermia as an immune modulator with checkpoint inhibitors and radiotherapy
|
Minnaar, C.A.
|
|
2019
|
110 |
S1 |
p. S19-S20
|
artikel
|
| 54 |
Modulation of AML-blasts with clinically approved response modifiers to leukemia-derived dendritic cells (DCleu) ex vivo: DC-, T-cell- and cytokine profiles are predictive for antileukemic T-cell reactivity
|
Fischer, Z.
|
|
2019
|
110 |
S1 |
p. S27-S28
|
artikel
|
| 55 |
Monitoring the effect of immunomodulatory treatment on the immune repertoire using the IGX platform
|
Fuchs, P.
|
|
2019
|
110 |
S1 |
p. S29-S30
|
artikel
|
| 56 |
Morphological consequences for noncapsular lymphoid tissue in the case of malignancy of GERD
|
Azhken, B.T.
|
|
2019
|
110 |
S1 |
p. S30
|
artikel
|
| 57 |
Multispectral imaging for quantitative and compartment specific immune profiling of cancer tissue
|
Wendik, B.
|
|
2019
|
110 |
S1 |
p. S12-S13
|
artikel
|
| 58 |
Myeloid cells mediates the accelerated growth of tumor in high-fat diet-fed mice
|
Tran, T.
|
|
2019
|
110 |
S1 |
p. S7
|
artikel
|
| 59 |
Omental fat in ovarian cancer induces lymphangiogenesis – The role of an adipose-rich microenvironment in tumor progression and metastatic dissemination
|
Starrach, V.F.
|
|
2019
|
110 |
S1 |
p. S6
|
artikel
|
| 60 |
Oncolysis dominated therapeutic effect of LCMV-GP – pseudotyped vesicular stomatitis virus in a syngeneic lung cancer model
|
Schreiber, L.
|
|
2019
|
110 |
S1 |
p. S15-S16
|
artikel
|
| 61 |
Overall responses and survival in RCC on pegilodecakin with anti-PD-1
|
Naing, A.
|
|
2019
|
110 |
S1 |
p. S1-S2
|
artikel
|
| 62 |
Overshooting neutrophil attraction by osteopontin inhibits liver regeneration after partial hepatectomy
|
Pereyra, D.
|
|
2019
|
110 |
S1 |
p. S33-S34
|
artikel
|
| 63 |
Parasites and immunotherapy: Immunostimulatory effect of Leishmania spp. in cancer treatment
|
Erdogan, M.
|
|
2019
|
110 |
S1 |
p. S33
|
artikel
|
| 64 |
PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer
|
Nada, M.H.
|
|
2019
|
110 |
S1 |
p. S23
|
artikel
|
| 65 |
Phase I trial of combination dendritic vaccine and immune checkpoint blockade for prevention of postoperative glioblastoma recurrence
|
Chen, L.
|
|
2019
|
110 |
S1 |
p. S21
|
artikel
|
| 66 |
Prevention of tumor ulceration in mice – Mammary fat pad injection of tumor cells
|
Obodozie, C.
|
|
2019
|
110 |
S1 |
p. S16
|
artikel
|
| 67 |
Probing the interaction of macrophages in the pancreatic cancer microenvironment using 3D engineered rollable tumour (TRACER)
|
Co, I.
|
|
2019
|
110 |
S1 |
p. S9
|
artikel
|
| 68 |
Reprogramming of M2-like macrophages to M1-like phenotype by tumor-antigen specific CD4+ T cells
|
Eisel, D.
|
|
2019
|
110 |
S1 |
p. S6-S7
|
artikel
|
| 69 |
Role of B lymphocytes in two types of precancerous liver diseases (PLD)
|
Petriv, N.
|
|
2019
|
110 |
S1 |
p. S34
|
artikel
|
| 70 |
Stress granule Y-box-binding protein 1 predicts prognosis in colorectal liver metastases independent and superior to DNA damage
|
Laengle, J.
|
|
2019
|
110 |
S1 |
p. S32
|
artikel
|
| 71 |
Study of IDO1 gene expression in histological variants of colorectal carcinoma
|
Turpín Sevilla, M.C.
|
|
2019
|
110 |
S1 |
p. S20-S21
|
artikel
|
| 72 |
Table of Contents
|
|
|
2019
|
110 |
S1 |
p. v
|
artikel
|
| 73 |
Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on tumor cells
|
Hatterer, E.
|
|
2019
|
110 |
S1 |
p. S13-S14
|
artikel
|
| 74 |
T cell repertoire convergence and clonal expansion in cytomegalovirus infection: Implications for the biomarker use of TCR-seq
|
Looney, T.
|
|
2019
|
110 |
S1 |
p. S29
|
artikel
|
| 75 |
The nonessential amino acid proline enhances migration and proliferation of human melanoma cells
|
Mayr, K.
|
|
2019
|
110 |
S1 |
p. S10-S11
|
artikel
|
| 76 |
The panta rhei of breast cancer: Gene expression timeline analysis during progression of microinvasive breast cancer microenvironment
|
Lessi, F.
|
|
2019
|
110 |
S1 |
p. S7
|
artikel
|
| 77 |
The phytochemicals Curcumin and Vitamin C act as immunosensitizer
|
Luzbetak, M.
|
|
2019
|
110 |
S1 |
p. S18
|
artikel
|
| 78 |
Tissue slice culture platform: A slice of reality in drug development
|
Garcon, F.
|
|
2019
|
110 |
S1 |
p. S6
|
artikel
|
| 79 |
Tumor-specific immune responses after short-term BRAF-inhibitor induction in patients with melanoma resistant to checkpoint inhibitors
|
Gokuldass, A.
|
|
2019
|
110 |
S1 |
p. S26
|
artikel
|
| 80 |
Tumour-infiltrating lymphocytes influence prognosis in Human Papillomavirus-positive cervical and oropharyngeal cancer: A systematic review
|
Anderson, C.D.
|
|
2019
|
110 |
S1 |
p. S31
|
artikel
|
| 81 |
Viral sensitizers potential infection of cancer cells via NF-kappaB
|
Phan, M.
|
|
2019
|
110 |
S1 |
p. S22-S23
|
artikel
|
Tijdschrift beschrijving